testified that the BACPAC
bill is vague on many provisions and would undercut clearer, possibly better Medicare reimbursement provisions in the Patient Protection and Affordable Care Act of 2010 (PPACA), and in the Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014, a law that fleshed out PPACA Medicare reimbursement provisions.
The probe mix consisted of the following bacterial artificial chromosome clones (Children's Hospital Oakland Research Institute, BACPAC
Resource Center): RP11-25O17, RP11-126L4, RP11-335I9, RP11-167M22, RP1130G23, and RP11-275J11 for PPARG; and RP11339F22, RP11-97J14, RP11-65I12, and RP11-141B14 for PAX8.
Other show topics include FDA and cGMP and post-approval reporting requirements, cGMP and BACPAC
compliance, regulatory challenges for bulk suppliers, regulatory compliance through customer relations, technology, pre-manufacture notification process and R&D productivity.